A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Nature Medicine2018Vol. 24(2), pp. 186–193
Citations Over TimeTop 1% of 2018 papers
Marc L. Hyer, Michael A. Milhollen, Jeff Ciavarri, Paul Fleming, Tary Traore, Darshan S. Sappal, Jessica J. Huck, Judy Shi, James M. Gavin, Jim Brownell, Yang Yu, Bradley Stringer, Robert Griffin, Frank J. Bruzzese, Teresa A. Soucy, Jennifer Duffy, Claudia Rabino, Jessica Riceberg, Kara M. Hoar, Anya Lublinsky, Saurabh Menon, Michael D. Sintchak, Nancy J. Bump, Sai Murali Krishna Pulukuri, Steven Langston, Stephen Tirrell, Mike Kuranda, Petter O. Veiby, John Newcomb, Ping Li, Jing Wu, Josh Powe, Lawrence R. Dick, Paul D. Greenspan, Katherine Galvin, Mark Manfredi, Chris Claiborne, Benjamin Amidon, Neil Bence
Related Papers
- → P53: Stability from the Ubiquitin–Proteasome System and Specific 26S Proteasome Inhibitors(2022)29 cited
- → Autoregulation of the 26S proteasome by in situ ubiquitination(2014)69 cited
- → HECT ubiquitin ligases as accessory proteins of the plant proteasome(2022)17 cited
- The Double Effects of Proteasome Inhibitor on Neuron(2006)
- Ubiquitin-like Protein FAT10-mediated Proteasome Degradation(2014)